2024-11-15 - Analysis Report
## Teladoc Health Inc. (TDOC) Stock Analysis

This report provides a comprehensive analysis of Teladoc Health Inc. (TDOC) stock, covering its performance, financial health, and recent developments.

**1. Performance Comparison with S&P 500 (VOO):**

Teladoc Health (TDOC) has significantly underperformed the S&P 500 (VOO) over the past years. While VOO has achieved a cumulative return of 177.02%, TDOC has delivered a return of only 54.19%. This results in a substantial divergence of -122.83, placing it in the 31st percentile of historical performance relative to the benchmark index.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 83.4% | 54.5% | 45.0% | 1.3 | 6.0 |
| 2016-2018  | 175.5% | 46.7% | 143.2% | 1.7 | 8.5 |
| 2017-2019  | 407.4% | 46.7% | 355.7% | 1.8 | 14.4 |
| 2018-2020  | 452.4% | 46.7% | 405.0% | 0.7 | 34.4 |
| 2019-2021  | 90.6% | 55.8% | -9.5% | 0.5 | 15.8 |
| 2020-2022  | -71.6% | 61.0% | -95.2% | 0.8 | 4.1 |
| 2021-2023  | -89.3% | 64.9% | -124.2% | 1.9 | 3.7 |
| 2022-2024  | -89.9% | 45.9% | -120.4% | 1.9 | 1.7 |

The data reveals a volatile performance with significant drawdowns, particularly in recent years.  The Alpha and Beta values indicate that TDOC has outperformed the market in some periods (positive Alpha) but has been more volatile (higher Beta).

**2. Recent Price Movement:**

* **Last Closing Price:** $9.57 (Last Market: $9.04)
* **5-day Moving Average:** $9.56
* **20-day Moving Average:** $9.2
* **60-day Moving Average:** $8.57

The stock price is currently above all three moving averages, suggesting a potential upward trend. However, the recent market price of $9.04 indicates a potential slight decline, indicating possible short-term volatility.

**3. Technical Indicators:**

* **RSI:** 64.31
* **PPO:** 0.45
* **Delta_Previous_Relative_Divergence:** -0.4 (Short-term downtrend)
* **Expected Return:** 0.0% (Long-term potential compared to S&P 500)

The RSI value suggests that the stock is in overbought territory, potentially indicating a short-term correction. The PPO value shows a positive momentum but is relatively low, implying that the upward trend might be weakening. The negative Relative Divergence indicates a short-term downtrend, suggesting potential weakness in the near future. The expected return of 0.0% suggests that the stock is not expected to outperform the market in the long term.

**4. Recent Earnings and Outlook:**

| Date       | EPS | Revenue |
|------------|-----|---------|
| 2024-10-31 | -0.19 | 0.64 B$ |
| 2024-08-01 | -4.92 | 0.64 B$ |
| 2024-04-26 | -0.49 | 0.65 B$ |
| 2023-10-27 | -0.35 | 0.66 B$ |
| 2024-10-31 | -0.35 | 0.66 B$ |

The most recent earnings (2024-10-31) show a loss of $0.19 per share, exceeding analyst expectations by $0.05. The company's revenue remains stable at $0.64 billion. While revenue is stable, the continued losses raise concerns about Teladoc's profitability and future growth potential.  

**5. Financial Information:**

* **Revenue and Profitability:** Teladoc has exhibited stable revenue growth, but the company is consistently experiencing losses. Profit margins have been around 70%, but with a significant drop in the latest quarter.
* **Capital and Profitability:** Equity has been fluctuating, and Return on Equity (ROE) has been negative for the past four quarters. This suggests a significant struggle for the company to generate profits.

**6. News and Recent Issues:**

Recent news and information on Teladoc Health Inc. (TDOC) are needed for a comprehensive analysis.  Please provide recent news articles and company announcements, particularly focusing on:

* **Earnings Reports:** Look for any analysis of the latest earnings report from sources like Shacknews.
* **Market Outlook:** Analyze market sentiment towards TDOC, identifying any bullish or bearish signals from analysts or market commentators.
* **Analyst Opinions:** Provide insights from analysts on TDOC's performance and future prospects, using sources like FINBOLD.
* **Performance Highlights:** Highlight any significant developments or events that have impacted TDOC's performance in recent months.

**7.  Overall Analysis:**

Teladoc Health Inc. (TDOC) has underperformed the market significantly in recent years. The stock has experienced substantial drawdowns and is currently showing mixed signals, with some technical indicators indicating potential weakness. While revenue remains stable, the company is facing challenges with profitability, with recent earnings demonstrating continued losses. 

The analysis of financial data shows a company struggling to generate profits despite stable revenue. The lack of recent news and information on TDOC limits the ability to provide a complete picture of the company's current situation. 

For a more informed decision, it is crucial to consider recent news and analyst opinions on TDOC's future prospects. In the absence of these details, investing in TDOC requires careful consideration of the risks associated with its current financial performance and outlook.

This report provides a starting point for understanding TDOC's situation. However, further research is needed to evaluate recent news and analyst opinions, which can provide a more complete assessment of the company's future prospects. 
